Leadership and delivery of the medical agenda, including Field Medical, Brand Medical Strategy, and cross-functional strategic initiatives for the Vaccines unit of a Global FTSE-100 Pharmaceutical company.
What was the challenge?
Our Client is committed to developing and delivering transformative vaccines and antibodies, providing long-lasting immunity to millions of people, where the burden of disease is greatest.
Within this Business Unit, the Medical Affairs function continues to grow and shape the direction of, and support for, new and existing brands, focusing on vaccines and mono-clonal antibodies to protect populations.
As part of this effort, the Medical Execution team plays a pivotal role ensuring that both the Client’s long-term strategies and day-to-day operations are consistent across all of the Client’s brands. Additionally, they guide field medical activities and spearhead key strategic initiatives.
The Medical Execution team within Vaccines & Immunotherapies (V&I) oversee various crucial areas, including Field Medical, Brand Medical Strategy, and cross-functional strategic initiatives. To ensure that the global strategy is adopted at local levels and that valuable local insights are communicated back to the global teams, the Medical Execution team need to collaborate cross-functionally with several internal teams and external partners, including liaising with country-based Marketing Companies (MCs).
How did we help?
Moorhouse partnered directly with the Medical Affairs team to provide a range of services, including:
- Project Management, Governance, and Strategy: We were embedded within the wider Global Vaccines Medical Affairs team, providing essential project management, governance, and strategic support.
- Brand Strategy: We took the lead in central coordination, development, and consolidation of medical strategy plans for various brands. Our work was pivotal in shaping operational plans, where we articulated the strategic direction and ensured consistent alignment across all cross-functional activities, deliverables, and tactics.
- Field Medical: Our leadership extended to developing and coordinating field medical strategic plans across the entirety of the Client’s brand portfolio. We crafted key performance indicators in alignment with the Client’s ambition for next-generation Medical Science Liaisons (MSLs), focusing on tangible impact and outcomes.
- Strategic Initiatives: We were instrumental in advancing several strategic initiatives for the client. Our role was to ensure these initiatives were effectively conceptualised, planned, and rolled out.
- Product Launch: We were at the forefront of collaborating with both Medical Affairs and the broader Vaccines team for the launch of a new product. This included liaising with Commercial teams playing a central role in the planning, preparation, and successful launch of the product.
What was the impact?
Benefits of our work included:
- New methodologies and operational standards were seamlessly integrated into the Vaccines strategy.
- The field medical strategic plan was crafted and executed, aligning with initial specifications and deadlines. Additionally, we played a pivotal role in the development and execution of key strategic initiatives, further bolstering the client’s commitment to innovation and excellence.
- Our endeavours have positioned the broader initiative at the forefront, accentuating its leadership role in the sphere of vaccines and immunotherapy.
We’re always here to help

